ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0724
0,00%
Bitcoin
63.847,76
-0,07%
Brent Oil
82,765
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. AVEO Pharmaceuticals Inc (AVEO)

  7. AVEO Pharmaceuticals Inc (AVEO) Notícias

AVEO

AVEO Pharmaceuticals (AVEO)

AVEO Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVEO
DataHoraFonteTítuloCódigoCompanhia
28/03/202416:22GlobeNewswire Inc.CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory CommitteeNASDAQ:AVEOAVEO Pharmaceuticals Inc
25/03/202409:10GlobeNewswire Inc.AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory CommitteeNASDAQ:AVEOAVEO Pharmaceuticals Inc
06/02/202410:10GlobeNewswire Inc.AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The OncologistNASDAQ:AVEOAVEO Pharmaceuticals Inc
16/01/202409:30GlobeNewswire Inc.AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)NASDAQ:AVEOAVEO Pharmaceuticals Inc
30/01/202318:08Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:AVEOAVEO Pharmaceuticals Inc
24/01/202308:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AVEOAVEO Pharmaceuticals Inc
19/01/202319:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
19/01/202319:05Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AVEOAVEO Pharmaceuticals Inc
19/01/202318:47Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AVEOAVEO Pharmaceuticals Inc
19/01/202318:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AVEOAVEO Pharmaceuticals Inc
19/01/202318:35GlobeNewswire Inc.LG Chem Completes Acquisition of AVEO OncologyNASDAQ:AVEOAVEO Pharmaceuticals Inc
18/01/202310:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
23/12/202218:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
25/11/202210:09Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
15/11/202210:33Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
11/11/202219:37ValueWalkIs Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?NASDAQ:AVEOAVEO Pharmaceuticals Inc
10/11/202201:26TipRanksSVB Securities Sticks to Its Hold Rating for AVEO Pharma (AVEO)NASDAQ:AVEOAVEO Pharmaceuticals Inc
10/11/202201:16TipRanksAVEO Pharma (AVEO) Receives a Hold from Robert W. BairdNASDAQ:AVEOAVEO Pharmaceuticals Inc
07/11/202218:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVEOAVEO Pharmaceuticals Inc
01/11/202218:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
28/10/202218:05TipRanksJonesTrading Reaffirms Their Hold Rating on AVEO Pharma (AVEO)NASDAQ:AVEOAVEO Pharmaceuticals Inc
24/10/202209:50TipRanksAnalysts Conflicted on These Healthcare Names: AVEO Pharma (AVEO) and HCA Healthcare (HCA)NASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202216:15Dow Jones NewsAVEO Pharma Shares Soar After LG Chem Takeover NewsNASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202214:45TipRanksH.C. Wainwright downgrades AVEO Pharma (AVEO) to a HoldNASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202208:54TipRanksAVEO Soars on LG Chem DealNASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202208:35TipRanksJonesTrading Keeps Their Buy Rating on AVEO Pharma (AVEO)NASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202207:26Dow Jones NewsAVEO Pharmaceuticals Shares Soar on Takeover by LG ChemNASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202207:05Dow Jones NewsLG Chem to Acquire AVEO Pharmaceuticals for $566 MillionNASDAQ:AVEOAVEO Pharmaceuticals Inc
14/10/202201:05TipRanksAVEO Pharma (AVEO) Gets a Buy from Robert W. BairdNASDAQ:AVEOAVEO Pharmaceuticals Inc
14/10/202200:55TipRanksAVEO Pharma (AVEO) Receives a Buy from SVB SecuritiesNASDAQ:AVEOAVEO Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVEO

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
GOLL4
GOL PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
AZEV4
AZEVEDO PN
BOV
AZUL4
AZUL PN
BOV
PRIO3
PETRORIO ON
BOV
HETA4
HERCULES PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados